Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol in the Treatment of Opioid Use Disorder
NCT06206291Phase 2Completed
- Start
- Oct 2023
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of cannabidiol in opioid use disorder (OUD). Started Oct 2023; status: completed.
02
Drugs
cannabidiol
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT06206291.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06206291.